Please login to the form below

Not currently logged in
Email:
Password:

New appointment at Synexus

Synexus has appointed Jeremy Hickling as senior vice president of portfolio management

Synexus has appointed Jeremy Hickling as senior vice president of portfolio management. Jeremy has 11 years' industry experience and brings significant, senior level knowledge to his new role.

Michael Fort, Synexus' chief executive, said: "We had a very successful and exciting 2009, culminating in our acquisition of ClinPharm in Germany. With Jeremy on board, it is important that we continue to expand our business development by demonstrating to a wider audience how we can help pharma, biotechs and CROs reduce costs and speed up clinical trials."

Jeremy, was previously a senior director within the late phase PACE group for leading contract research organisation PAREXEL where he was responsible for key projects and relationship management, study design and strategy. Prior to this he worked as the head of UK planning and operations for Biogen Idec Inc.

Jeremy said: "I've been very fortunate to work for some of the best organisations in the pharma industry. The opportunity to work with Synexus gives me the chance to be involved with a company that is not only growing rapidly, but is also making real changes to the clinical trials industry. I am keen to be a part of that and to demonstrate the real benefits the Synexus model offers to pharma and CRO clients alike."

Synexus is based outside Manchester and is the world's largest multinational organisation specialising in the recruitment of patients and the running of trials at its own dedicated research centres.

19th January 2010

Share

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Cuttsy + Cuttsy

Here at Cuttsy+Cuttsy, we believe in making the world a better place by bringing trusted, accessible information to all and...

Latest intelligence

Top-10 Reasons Why You Should be Adding Asynchronous Virtual Touchpoints Between Your Real-time Meetings
...
Flu
Influenza – the risk to vulnerable populations
Why we can't get complacent about flu vaccination...
dementia
Alzheimer’s Research UK highlights socio-economic inequalities in dementia risk
The charity aims to improve the number of women participating in dementia research and grow awareness of dementia risk factors...